Interestingly, we found a novel co-regulation of FOXA1 and GATA3 with a common binding partner of AP-1 complex like breast cancers [58, 59] that appears to drive activity of distal enhancers, but not promoters. This evidence concerns the gene FOXA1 and breast cancer.